AGONISTEN VON DREADD
European patent · EP3749325 · In force
Register entry
- Publication number
- EP3749325
- Application number
- EP19706192
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 6, 2019
- Published
- Dec 16, 2020
- Granted
- Apr 8, 2026
- Protection ends at the latest
- Feb 5, 2039
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 31/5517 (2006.01)C07D 243/38 (2006.01)A61P 25/00 (2006.01)
- Priority
- US 201862627527 P 07.02.2018
- PCT application
- PCT/US2019/016892 06.02.2019
- PCT publication
- WO2019/157083 15.08.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 8, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 08.04.2026
Parties
Holder
Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive, Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, US
3400 N. Charles Street, Baltimore MD 21212, US
Inventor
Baltimore, Maryland 21224, US
Frederick, Maryland 21701, US
Ellicott City, Maryland 21043, US
Timonium, MD 21093, US
Baltimore, Maryland 21224, US
Baltimore, Maryland 21212, US
Odenton, Maryland 21113, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.